07.02.2012
Ausgewählte Listed Private Equity Unternehmen
HBM BioVentures AG
HBM BioVentures AG is a direct private equity investment company managed by HBM Partners Limited. It was founded in 2001 and has been listed on the Swiss Stock Exchange since February 2008. The company pursues a global venture and growth capital investment strategy in the biotechnology and healthcare sector.
Company | HBM BioVentures AG |
Website | |
ISIN | CH0012627250 |
Bloomberg Ticker | HBMN SW |
Exchange | Swiss Stock Exchange |
Listed Private Equity since | 14 February 2008 |
LPX Classification | Direct private equity investment |
Trading Currency | CHF |
LPX Index Membership | LPX50, LPX Composite, LPX Europe, LPX Direct, LPX Venture |
Factsheet |
|
